The Company Store Announces Exclusive Collaboration with Stoffer Home

The collection combines timeless design with everyday comfort in bedding, table linens, and loungewear The Company Store, a trusted name in premium home textiles for more than 115 years, announces its collaboration with Stoffer Home, the design brand led by mother-daughter duo Jean Stoffer and Grace Start. The new Stoffer Home × The Company Store […]

Monster Energy’s Finley Melville Ives Takes 1st Place in Freeski Halfpipe at the 2026 Toyota U.S. Grand Prix at Aspen Snowmass

— 19-Year-Old Melville Ives from New Zealand Claims Victory in Superpipe at Buttermilk Mountain — Women’s Freeski Halfpipe: 22-Year-Old Zoe Atkin from Park City, Utah, Takes 2nd Place — Women’s Freeski Slopestyle: 24-Year-Old Megan Oldham from Parry Sound, Canada Earns 2nd Place — Men’s Snowboard Slopestyle: 20-Year-Old Monster Army Rider Dane Menzies Claims 3rd Place

Leadgene Biosolutions Expands Its Product Portfolio Following Strategic Integration, Advancing Early-Stage Mixing and Long-Term Metabolic Insight

Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line development and long-term metabolic research, enabling researchers to make more informed decisions earlier in their workflows. Early-Stage Cell Line Development with Defined Mixing and Real-Time Insight For biopharmaceutical companies, Leadgene

If you purchased a Lotrimin or Tinactin product covered by Bayer’s October 2021 recall (which includes products purchased from September 2018 to October 2021), You Could Get a Cash Payment From a Settlement

The following statement is being issued by Rust Consulting, Inc. regarding Huertas et al. v. Aeropres Corp., et al., Case No, 2:21-cv-20021. There is a Proposed Settlement in a class action lawsuit against Aeropres Corporation (“Aeropres”), Aux Sable Liquid Products LP (“Aux Sable”), Bayer HealthCare LLC and Bayer U.S. LLC (collectively, “Bayer”), Beiersdorf Inc., Beiersdorf

Frost & Sullivan: Scala Data Centers Recognized for Leadership in Latin America’s Digital Infrastructure

Frost & Sullivan honors Scala Data Centers with the 2025 Latin American Competitive Strategy Leadership Recognition Scala Data Centers, the leading hyperscale sustainable data center platform in Latin America, has been recognized with the 2025 Latin American Competitive Strategy Leadership Recognition by Frost & Sullivan. This prestigious accolade highlights Scala's strategy and sustainability leadership, rapid

BostonGene Recognized by Frost & Sullivan for 2025 Global Technology Innovation Leadership in AI-Driven Precision Oncology Solutions

Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for Tumor and Immune Biology Frost & Sullivan is pleased to announce that BostonGene has been recognized for 2025 Global Technology Innovation Leadership in the AI-driven Precision Oncology Solutions sector for its outstanding achievements in Technology Innovation Leadership. This recognition

Lightspeed Commerce Launches a New Multi-Brand Shopping and Ordering Experience in the Marketplace

Retailers can now access and order from thousands of brands–all directly from within NuOrder and the Lightspeed point of sale system Lightspeed Commerce Inc. (NYSE: LSPD) (TSX: LSPD) (“Lightspeed” or the “Company”), the unified omnichannel platform powering ambitious retail, golf, and hospitality businesses in over 100 countries, today unveiled a new centralized, multi-brand shopping and

CLUB® CRACKERS BRINGS TWO CRAVE-WORTHY INNOVATIONS TO THE SNACK AISLE WITH NEW CLUB® MINIS HIDDEN VALLEY(TM) RANCH AND CLUB® EXTRA BUTTERY

Two new launches deliver fan-favorite flavor and elevated indulgence Key News Bites: — NEW Club® Minis Hidden Valley Ranch brings craveable ranch flavor to Club’s bite-sized Minis format — NEW Club® Extra Buttery brings a bolder buttery flavor to the classic Club® cracker — Both innovations begin rolling out nationally starting in January, with expanded

Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook

(NASDAQ:AKBA), Positioned to increase depth of Vafseo prescribing entering 2026 with access to approximately 275,000 patients First patient dosed in Praliciguat Phase 2 clinical trial studying focal segmental glomerulosclerosis (FSGS) AKB-097 Phase 2 rare kidney disease basket trial scheduled to begin in 2H 2026 with initial data expected in 2027 CAMBRIDGE, Mass., Jan. 12, 2026

Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update

(NasdaqGM:SENS), Preliminary unaudited revenue expected to be approximately $14.2 million for Q4 2025, an increase of 71% year-over-year Introduced 2026 revenue guidance of $58-$62 million Expects to report fourth quarter and full year 2025 financial results on March 2, 2026 GERMANTOWN, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NASDAQ: SENS) a medical

Scroll to Top